In this week’s View, Dr. Eagle looks at findings from the Evolut Low Risk trial in which self-expanding transcatheter aortic valve replacement (TAVR) versus surgery at six years in low-risk patients ...
Inflammation plays a central role in the pathogenesis of atherosclerosis and cardiovascular disease. 1 Atherosclerosis in particular is an inflammatory process that involves endothelial dysfunction, ...
Chronic consumption of high levels of caffeine a day can lead to an increase in high heart rate and blood pressure that persists after resting from a step test, increasing the risk of cardiovascular ...
The 2023 European Society of Hypertension (ESH) and 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines both emphasize proper blood pressure (BP) ...
Health care professionals should explore the use of glucagon-like peptide-1 receptor agonists (GLP1RAs) for cardiovascular risk reduction and their broader impacts on cardiometabolic health beyond ...
Beta-blocker therapy following myocardial infarction (MI) was the primary focus of a hot line session at ESC Congress 2025. Study investigators presented findings from the REBOOT-CNIC and ...
Artificial intelligence (AI)-based echocardiogram (ECG) analysis significantly improved STEMI detection, reduced false activations and enhanced recognition of nonconventional presentations, according ...
In patients with diabetes and multivessel coronary artery disease undergoing PCI, a ticagrelor-based dual antiplatelet therapy (DAPT) regimen did not offer the same level of benefit at preventing ...
Four major studies presented at AHA 2025 are reshaping strategies for managing atrial fibrillation (AFib) in complex clinical scenarios. OCEAN addresses whether ongoing anticoagulation is necessary ...
The ACC's Guideline Clinical App is the mobile home of clinical guideline content and tools for clinicians caring for patients with cardiovascular disease. The App brings the guidelines closer to the ...
Findings from the TACSI and TOP-CABG trials presented at ESC Congress 2025 add to discussions around antiplatelet therapy following CABG. In TACSI, simultaneously published in NEJM, researchers ...
The American Heart Association (AHA)'s new scientific statement advocates a more personalized approach to managing high blood pressure in patients who are hospitalized. By introducing revised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results